Immunovant, Inc.

Historical 13F Holders

Symbol
IMVT
CUSIP
45258J102
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 200 95.2 M $1.54 B
2025 Q2 184 96.3 M $1.54 B
2025 Q1 218 94.2 M $1.61 B
2024 Q4 213 82.3 M $2.04 B
2024 Q3 211 79.7 M $2.27 B
2024 Q2 223 76.5 M $2.02 B
2024 Q1 245 75.0 M $2.42 B
2023 Q4 264 72.0 M $3.03 B
2023 Q3 223 69.4 M $2.67 B
2023 Q2 162 56.9 M $1.08 B
2023 Q1 155 58.3 M $905 M
2022 Q4 143 59.7 M $1.06 B
2022 Q3 118 42.7 M $238 M
2022 Q2 100 40.1 M $157 M
2022 Q1 122 43.4 M $240 M
2021 Q4 131 38.0 M $324 M
2021 Q3 134 33.8 M $294 M
2021 Q2 134 38.6 M $408 M
2021 Q1 134 40.4 M $654 M
2020 Q4 151 40.6 M $1.88 B
2020 Q3 119 39.8 M $1.40 B
2020 Q2 90 28.6 M $696 M
2020 Q1 42 12.6 M $194 M
2019 Q4 26 11.6 M $176 M